Walgreens Boots Alliance Inc

Walgreens Boots Alliance Inc(WBA)股票分析

$11.980

+0.060 (+0.50%)收盤時

Loading chart…
最高
12.110
開盤
11.915
成交量加權均價
12.00
成交量
452.08M
市值
10.52B
最低
11.900
成交金額
5.42B
企業價值/稅息折舊攤銷前利潤(TTM)
11.73

Walgreens Boots Alliance, Inc. is an integrated healthcare, pharmacy and retailing company. The Company’s segments include U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment includes the Walgreens business, which includes the operations of retail drug stores, health and wellness services, and specialty and home delivery pharmacy services, and its equity method investment in Cencora, Inc. The International segment consists of pharmacy-led health and beauty retail businesses outside the United States and a pharmaceutical wholesaling and distribution business in Germany. The pharmacy-led health and beauty retail businesses include Boots branded stores in the United Kingdom, the Republic of Ireland and Thailand, and the Benavides brand in Mexico. The Company's U.S. Healthcare segment is a consumer-centric, technology-enabled healthcare business that engages consumers through a personalized, omni-channel experience across the care journey.

分析師評級(24)

-4.42% 下跌空間
買進
15 買進
9 持有
0 賣出
目前: 11.98
最低
11.45
平均
11.45
最高
11.45

Deutsche Bank

2025-02-28

目標價

$9

強烈賣出

Truist Securities

2025-01-31

目標價

$12

持有

Truist Securities

2025-01-16

目標價

$13

持有

RBC Capital

2025-01-15

目標價

$12

持有

B of A Securities

2025-01-13

目標價

$8.5

賣出

估值指標

Walgreens Boots Alliance Inc(WBA)目前預期本益比為 7.78,5 年平均預期本益比為 7.94。

預期本益比

合理
5 年均值 P/E
7.94
目前P/E
7.78
高估
9.46
低估
6.42

預期 EV/EBITDA

合理
5 年均值 EV/EBITDA
12.24
目前EV/EBITDA
11.73
高估
13.37
低估
11.11

預期股價營收比

低估
5 年均值 P/S
0.17
目前P/S
0.07
高估
0.26
低估
0.07

Alphio AI 對 WBA 的價格情境

情境價格取自當年最後一個月度預測區間。機率為固定的模型權重(25 / 50 / 25),不構成保證。

樂

樂觀

樂觀 · 25%WBA

$10.84

情境價格

基

基準

基準 · 50%WBA

$10.13

情境價格

悲

悲觀

悲觀 · 25%WBA

$7.68

情境價格

事件時間軸

2025-09-02 (ET)

07:05:54

Cigna's Evernorth Health Allocates $3.5 Billion to Shields Health Solutions

2025-08-28 (ET)

04:55:00

Interactive Brokers set to take the place of Walgreens Boots Alliance in the S&P 500 starting on August 28.

2025-08-25 (ET)

17:17:42

Interactive Brokers set to take the place of Walgreens Boots Alliance in the S&P 500 starting on August 28.

資訊

WBA 常見問題 —— 由 Alphio AI 解答

Walgreens Boots Alliance, Inc. is an integrated healthcare, pharmacy and retailing company. The Company’s segments include U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment includes the Walgreens business, which includes the operations of retail drug stores, health and wellness services, and specialty and home delivery pharmacy services, and its equity method investment in Cencora, Inc. The International segment consists of pharmacy-led health and beauty retail businesses outside the United States and a pharmaceutical wholesaling and distribution business in Germany. The pharmacy-led health and beauty retail businesses include Boots branded stores in the United Kingdom, the Republic of Ireland and Thailand, and the Benavides brand in Mexico. The Company's U.S. Healthcare segment is a consumer-centric, technology-enabled healthcare business that engages consumers through a personalized, omni-channel experience across the care journey. It operates in the Consumer Non-Cyclicals sector (RETAIL-DRUG STORES AND PROPRIETARY STORES industry).

24 analysts cover WBA: 15 rate it Buy, 9 Hold and 0 Sell. The average price target is 11.45.

暫無貼文

註冊或登入後參與討論

本頁僅供研究參考,不構成投資建議。模型可能出錯。過往表現不代表未來結果。

開始交易